Adverum Biotechnologies

ADVM

3.03

+0.03

+0.8%

After Hours:

3.10

+0.07

+2.5%

Please Login or Register

Login|Register FREE

Stock Price
Open: 3.05
Prev. Close: 3.00
Low/Hi: 3.00 - 3.05
52-Week: 2.40 - 4.20
Volumes
Equity: 98,197
90-Day Avg: 243,779
Option:
90-Day Avg: 59
Volatility
Todays Stock Vol: 30.8
20-Day (HV): 77.3
52-Week (HV): 69.0
30-Day IV: 65.4 -7.2
IV Pct Rank: 60% Moderate
Fundamental
Div. Yield:
Earnings: 5-Mar (Est.)
P/E Ratio:
Market Cap: 135.1 M
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ADVM Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -13,829 -11,430 -16,099 -22,394
Change in Working Capital 356 -2,912 1,781 817
Depreciation Amortization Depletion and Accretion 752 656 603 487
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 2,736 2,265 1,898 12,748
Total Cash from Operating Activities -9,985 -11,421 -11,817 -8,342
Capital Expenditures -186 -469 -263 -924
Other Investing Cash Flow 2,811 -20,197 -138,591 0
Total Cash from Investing Activities 2,625 -20,666 -138,854 -924
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 53 155 187 203
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow -292 0 0 0
Total Cash from Financing Activities -239 155 187 203
Exchange Rate Effects -211 -114 -117 -38
Net Change in Cash -7,810 -32,046 -150,601 -9,101
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Net Income -113,747 -47,453 -28,634
Change in Working Capital 1,640 -1,221 10,046
Depreciation Amortization Depletion and Accretion 1,603 1,592 162
Deferred Taxes 0 0 0
Other Non-Cash Activities 72,138 11,744 9,548
Total Cash from Operating Activities -38,366 -35,338 -5,648
Capital Expenditures -2,412 -2,992 -943
Other Investing Cash Flow 41,187 -38,577 0
Total Cash from Investing Activities 38,775 -41,569 -943
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 949 139,287 165,982
Purchase and Retirement of Debt 100 0 2,000
Other Financing Cash Flow -493 -427 -2,540
Total Cash from Financing Activities 556 138,860 165,442
Exchange Rate Effects -143 -9 -11
Net Change in Cash 822 61,944 158,840